Wise Reasoning and Prosocial Behavior

Last registered on November 05, 2021

Pre-Trial

Trial Information

General Information

Title
Wise Reasoning and Prosocial Behavior
RCT ID
AEARCTR-0008488
Initial registration date
November 03, 2021
Last updated
November 05, 2021, 8:05 PM EDT

Locations

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information

Primary Investigator

Affiliation
RWI - Leibniz Institute for Economic Research

Other Primary Investigator(s)

PI Affiliation
University of Waterloo
PI Affiliation
RWI – Leibniz Institute for Economic Research
PI Affiliation
RWI – Leibniz Institute for Economic Research

Additional Trial Information

Status
On going
Start date
2021-10-12
End date
2023-12-31
Secondary IDs
Prior work
This trial is based on or builds upon one or more prior RCTs.
Abstract
This study aims to identify whether wise reasoning promotes prosocial behavior on the individual level. We investigate this by conducting a large-scale survey in several European countries. We measure wise reasoning on a general and on a specific scale of survey items. Prosocial behavior is firstly measured as individual behavior in a donation experiment and secondly through a set of survey items on real-world behavior, such as blood donations and behavior during the Corona pandemic.
External Link(s)

Registration Citation

Citation
Andor, Mark A. et al. 2021. "Wise Reasoning and Prosocial Behavior." AEA RCT Registry. November 05. https://doi.org/10.1257/rct.8488-1.0
Sponsors & Partners

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2021-10-12
Intervention End Date
2021-11-07

Primary Outcomes

Primary Outcomes (end points)
See Analysis Plan
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
See Analysis Plan
Experimental Design Details
Not available
Randomization Method
See Analysis Plan
Randomization Unit
See Analysis Plan
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
See Analysis Plan
Sample size: planned number of observations
See Analysis Plan
Sample size (or number of clusters) by treatment arms
See Analysis Plan
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
See Analysis Plan
IRB

Institutional Review Boards (IRBs)

IRB Name
IRB Approval Date
IRB Approval Number
Analysis Plan

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information